PAPACCIO, Federica
PAPACCIO, Federica
Dipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction"
2023-01-01 Papaccio, Federica; García-Mico, Blanca; Gimeno-Valiente, Francisco; Cabeza-Segura, Manuel; Gambardella, Valentina; Gutiérrez-Bravo, María Fernanda; Alfaro-Cervelló, Clara; Martinez-Ciarpaglini, Carolina; Rentero-Garrido, Pilar; Zúñiga-Trejos, Sheila; Carbonell-Asins, Juan Antonio; Fleitas, Tania; Roselló, Susana; Huerta, Marisol; Sánchez Del Pino, Manuel M; Sabater, Luís; Roda, Desamparados; Tarazona, Noelia; Cervantes, Andrés; Castillo, Josefa
3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients
2020-01-01 Cabeza, M; Papaccio, F; Bravo, Mfg; Gambardella, V; Alfaro-Cervello, C; Martínez-Ciarpaglini, C; Garzón-Lloría, Z; Rentero-Garrido, P; Zúñiga-Trejos, S; Seda-García, E; Gimeno-Valiente, F; Peña, A; Barrios, M; Tarazona, N; Roda, D; Cervantes, A; Fleitas, T; Castillo, J
A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial
2015-01-01 Fasano, M; Della Corte, Cm; Capuano, A; Sasso, Fc; Papaccio, F; Berrino, L; Ciardiello, F; Morgillo, F.
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo
2018-01-01 Mele, L; Paino, F; Papaccio, F; Regad, T; Boocock, D; Stiuso, P; Lombardi, A; Liccardo, D; Aquino, G; Barbieri, A; Arra, C; Coveney, C; La Noce, M; Papaccio, G; Caraglia, M; Tirino, V; Desiderio, V.
A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC
2019-01-01 Viscardi, G; Sparano, F; Di Liello, R; Casal, Ga; Ferreres, Rb; Bruixola, G; Gambardella, V; Zanaletti, N; Iacovino, Ml; Della Corte, Cm; Papaccio, F; Fasano, M; Ciardiello, F; Cervantes, A; Morgillo, F; Martorell, Pm; Molla, Mai
An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models
2020-01-01 Gambardella, V; Gimeno-Valiente, F; Cabeza, M; Papaccio, F; Zúñiga-Trejos, S; Carbonell-Asins, Ja; Rentero-Garrido, P; Huerta, M; Keränen, Sr; Cejalvo, Jm; Roda, D; Tarazona, N; Fleitas, T; Cervantes, A; Castillo, J
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSCLC cancer: a preliminary study to identify biomarkers of efficacy
2016-01-01 Barra, G; Pasquale, G; Della Corte, Cm; Papaccio, F; Orditura, M; Devita, F; Ciardiello, F; De Palma, R; Morgillo, F
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy
2017-01-01 Barra, G; Pasquale, G; Della Corte, C; Papaccio, F; Ciardiello, F; Morgillo, F; De Palma, R
Antitumoral efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models
2018-01-01 Morgillo, F; Della Corte, Cm; Alfieri, R; Petronini, P; La Monica, S; Papaccio, F; Ciardiello, F
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization
2012-01-01 Tirino, V; Desiderio, V; Paino, F; De Rosa, A; Papaccio, F; La Noce, M; Laino, L; De Francesco, F; Papaccio, G.
Circulating cancer stem cells: an interesting niche to explore
2020-01-01 Papaccio, F.
CNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations
2019-01-01 Papaccio, F; Valiente, Fg; Gutierrez-Bravo, Mf; Cabeza-Segura, M; Gambardella, V; Huerta, Mds; Martinez-Ciarpaglini, C; Alfaro-Cervello, C; Rentero-Garrido, P; Zúñiga-Trejos, S; Keranen, Sr; Fleitas, T; Tarazona, N; Perez, Dr; Cervantes, A; Castillo, J
Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development
2017-01-01 Papaccio, F; Paino, F; Regad, T; Papaccio, G; Desiderio, V; Tirino, V.
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer
2020-01-01 Tarazona, N.; Gimeno-Valiente, F.; Gambardella, V.; Huerta, M.; Rosello, S.; Zuniga, S.; Calon, A.; Carbonell-Asins, J. A.; Fontana, E.; Martinez-Ciarpaglini, C.; Eason, K.; Rentero-Garrido, P.; Fleitas, T.; Papaccio, F.; Moro-Valdezate, D.; Nyamundanda, G.; Castillo, J.; Espi, A.; Sadanandam, A.; Roda, D.; Cervantes, A.
Development of a living organoid biobank derived from colorectal cancer patients: Towards personalized medicine
2019-01-01 Papaccio, F; Gutierrez-Bravo, Mf; Cabeza-Segura, M; Gambardella, V; Huerta, M; Ciarpaglini, Cm; Keranen, Sr; Gimeno-Valiente, F; Fleitas, T; Llavero, Nt; Roda, D; Cervantes, A; Castillo, J
Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites
2017-01-01 Della Corte, Cm; Barra, G; Ciaramella, V; Papaccio, F; Viscardi, G; Esposito, G; Di Liello, R; Orditura, M; Troiani, T; De Palma, R; Ciardiello, F; Morgillo, F
Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites
2018-01-01 Morgillo, F; Della Corte, Cm; Viscardi, G; Di Liello, R; Papaccio, F; Ciardiello, F
Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence
2016-01-01 Esposito, G; Della Corte, Cm; Papaccio, F; Viscardi, G; Fasano, M; Troiani, T; Martinelli, E; Ciardiello, F; Morgillo, F
Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance
2016-01-01 Papaccio, F; Della Corte, Cm; Viscardi, G; Esposito, G; Fasano, M; De Vita, F; Orditura, M; Ciardiello, F; Morgillo, F
Efficacy of sequential treatment with first, second and third generation EGFR inhibitors and role of Hedgehog pathway in the acquisition of resistance in in vivo NSCLC models
2016-01-01 Della Corte, Cm; Papaccio, F; Viscardi, G; Esposito, G; Fasano, M; Castellone, D; Parascandolo, A; De Vita, F; Orditura, M; Ciardiello, F; Morgillo, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction" | 1-gen-2023 | Papaccio, Federica; García-Mico, Blanca; Gimeno-Valiente, Francisco; Cabeza-Segura, Manuel; Gambardella, Valentina; Gutiérrez-Bravo, María Fernanda; Alfaro-Cervelló, Clara; Martinez-Ciarpaglini, Carolina; Rentero-Garrido, Pilar; Zúñiga-Trejos, Sheila; Carbonell-Asins, Juan Antonio; Fleitas, Tania; Roselló, Susana; Huerta, Marisol; Sánchez Del Pino, Manuel M; Sabater, Luís; Roda, Desamparados; Tarazona, Noelia; Cervantes, Andrés; Castillo, Josefa | |
| 3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients | 1-gen-2020 | Cabeza, M; Papaccio, F; Bravo, Mfg; Gambardella, V; Alfaro-Cervello, C; Martínez-Ciarpaglini, C; Garzón-Lloría, Z; Rentero-Garrido, P; Zúñiga-Trejos, S; Seda-García, E; Gimeno-Valiente, F; Peña, A; Barrios, M; Tarazona, N; Roda, D; Cervantes, A; Fleitas, T; Castillo, J | |
| A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial | 1-gen-2015 | Fasano, M; Della Corte, Cm; Capuano, A; Sasso, Fc; Papaccio, F; Berrino, L; Ciardiello, F; Morgillo, F. | |
| A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo | 1-gen-2018 | Mele, L; Paino, F; Papaccio, F; Regad, T; Boocock, D; Stiuso, P; Lombardi, A; Liccardo, D; Aquino, G; Barbieri, A; Arra, C; Coveney, C; La Noce, M; Papaccio, G; Caraglia, M; Tirino, V; Desiderio, V. | |
| A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC | 1-gen-2019 | Viscardi, G; Sparano, F; Di Liello, R; Casal, Ga; Ferreres, Rb; Bruixola, G; Gambardella, V; Zanaletti, N; Iacovino, Ml; Della Corte, Cm; Papaccio, F; Fasano, M; Ciardiello, F; Cervantes, A; Morgillo, F; Martorell, Pm; Molla, Mai | |
| An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models | 1-gen-2020 | Gambardella, V; Gimeno-Valiente, F; Cabeza, M; Papaccio, F; Zúñiga-Trejos, S; Carbonell-Asins, Ja; Rentero-Garrido, P; Huerta, M; Keränen, Sr; Cejalvo, Jm; Roda, D; Tarazona, N; Fleitas, T; Cervantes, A; Castillo, J | |
| Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSCLC cancer: a preliminary study to identify biomarkers of efficacy | 1-gen-2016 | Barra, G; Pasquale, G; Della Corte, Cm; Papaccio, F; Orditura, M; Devita, F; Ciardiello, F; De Palma, R; Morgillo, F | |
| Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy | 1-gen-2017 | Barra, G; Pasquale, G; Della Corte, C; Papaccio, F; Ciardiello, F; Morgillo, F; De Palma, R | |
| Antitumoral efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models | 1-gen-2018 | Morgillo, F; Della Corte, Cm; Alfieri, R; Petronini, P; La Monica, S; Papaccio, F; Ciardiello, F | |
| Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization | 1-gen-2012 | Tirino, V; Desiderio, V; Paino, F; De Rosa, A; Papaccio, F; La Noce, M; Laino, L; De Francesco, F; Papaccio, G. | |
| Circulating cancer stem cells: an interesting niche to explore | 1-gen-2020 | Papaccio, F. | |
| CNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations | 1-gen-2019 | Papaccio, F; Valiente, Fg; Gutierrez-Bravo, Mf; Cabeza-Segura, M; Gambardella, V; Huerta, Mds; Martinez-Ciarpaglini, C; Alfaro-Cervello, C; Rentero-Garrido, P; Zúñiga-Trejos, S; Keranen, Sr; Fleitas, T; Tarazona, N; Perez, Dr; Cervantes, A; Castillo, J | |
| Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development | 1-gen-2017 | Papaccio, F; Paino, F; Regad, T; Papaccio, G; Desiderio, V; Tirino, V. | |
| Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer | 1-gen-2020 | Tarazona, N.; Gimeno-Valiente, F.; Gambardella, V.; Huerta, M.; Rosello, S.; Zuniga, S.; Calon, A.; Carbonell-Asins, J. A.; Fontana, E.; Martinez-Ciarpaglini, C.; Eason, K.; Rentero-Garrido, P.; Fleitas, T.; Papaccio, F.; Moro-Valdezate, D.; Nyamundanda, G.; Castillo, J.; Espi, A.; Sadanandam, A.; Roda, D.; Cervantes, A. | |
| Development of a living organoid biobank derived from colorectal cancer patients: Towards personalized medicine | 1-gen-2019 | Papaccio, F; Gutierrez-Bravo, Mf; Cabeza-Segura, M; Gambardella, V; Huerta, M; Ciarpaglini, Cm; Keranen, Sr; Gimeno-Valiente, F; Fleitas, T; Llavero, Nt; Roda, D; Cervantes, A; Castillo, J | |
| Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites | 1-gen-2017 | Della Corte, Cm; Barra, G; Ciaramella, V; Papaccio, F; Viscardi, G; Esposito, G; Di Liello, R; Orditura, M; Troiani, T; De Palma, R; Ciardiello, F; Morgillo, F | |
| Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites | 1-gen-2018 | Morgillo, F; Della Corte, Cm; Viscardi, G; Di Liello, R; Papaccio, F; Ciardiello, F | |
| Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence | 1-gen-2016 | Esposito, G; Della Corte, Cm; Papaccio, F; Viscardi, G; Fasano, M; Troiani, T; Martinelli, E; Ciardiello, F; Morgillo, F | |
| Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance | 1-gen-2016 | Papaccio, F; Della Corte, Cm; Viscardi, G; Esposito, G; Fasano, M; De Vita, F; Orditura, M; Ciardiello, F; Morgillo, F | |
| Efficacy of sequential treatment with first, second and third generation EGFR inhibitors and role of Hedgehog pathway in the acquisition of resistance in in vivo NSCLC models | 1-gen-2016 | Della Corte, Cm; Papaccio, F; Viscardi, G; Esposito, G; Fasano, M; Castellone, D; Parascandolo, A; De Vita, F; Orditura, M; Ciardiello, F; Morgillo, F |